Literature DB >> 15135901

Activation of the intracerebral cholinergic nerve fibers originating in the basal forebrain increases regional cerebral blood flow in the rat's cortex and hippocampus.

Akio Sato1, Yuko Sato, Sae Uchida.   

Abstract

In the rat, activation of the intracerebral cholinergic system originating in the basal forebrain and projecting to the cortex and hippocampus releases acetylcholine in the cortex and hippocampus, which results in vasodilation and an increase in regional cerebral blood flow (rCBF) in the cortex and hippocampus. The augmentation of rCBF is independent of both systemic blood pressure and regional metabolism. The intracerebral cholinergic fibers are able to act as autonomic nerve fibers for the regulation of cortical and hippocampal blood flow.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15135901     DOI: 10.1016/j.neulet.2004.01.004

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  25 in total

1.  The neuroprotective effect of curcumin and Nigella sativa oil against oxidative stress in the pilocarpine model of epilepsy: a comparison with valproate.

Authors:  Heba S Aboul Ezz; Yasser A Khadrawy; Neveen A Noor
Journal:  Neurochem Res       Date:  2011-07-13       Impact factor: 3.996

Review 2.  Cholinergic modulation of cognition: insights from human pharmacological functional neuroimaging.

Authors:  Paul Bentley; Jon Driver; Raymond J Dolan
Journal:  Prog Neurobiol       Date:  2011-06-17       Impact factor: 11.685

3.  Effect of basal forebrain stimulation on extracellular acetylcholine release and blood flow in the olfactory bulb.

Authors:  Sae Uchida; Fusako Kagitani
Journal:  J Physiol Sci       Date:  2017-05-12       Impact factor: 2.781

Review 4.  Neural circuitry and immunity.

Authors:  Valentin A Pavlov; Kevin J Tracey
Journal:  Immunol Res       Date:  2015-12       Impact factor: 2.829

Review 5.  Brain ischemia in patients with intracranial hemorrhage: pathophysiological reasoning for aggressive diagnostic management.

Authors:  Daniel Naranjo; Michal Arkuszewski; Wojciech Rudzinski; Elias R Melhem; Jaroslaw Krejza
Journal:  Neuroradiol J       Date:  2013-12-18

6.  Improvement of cerebellum redox states and cholinergic functions contribute to the beneficial effects of silymarin against manganese-induced neurotoxicity.

Authors:  Yassine Chtourou; Hamadi Fetoui; El Mouldi Garoui; Tahia Boudawara; Najiba Zeghal
Journal:  Neurochem Res       Date:  2011-10-28       Impact factor: 3.996

7.  Acetylcholine α7 nicotinic and dopamine D2 receptors are targeted to many of the same postsynaptic dendrites and astrocytes in the rodent prefrontal cortex.

Authors:  Aine M Duffy; Megan L Fitzgerald; June Chan; Danielle C Robinson; Teresa A Milner; Kenneth Mackie; Virginia M Pickel
Journal:  Synapse       Date:  2011-12       Impact factor: 2.562

Review 8.  The significance of the cholinergic system in the brain during aging and in Alzheimer's disease.

Authors:  R Schliebs; T Arendt
Journal:  J Neural Transm (Vienna)       Date:  2006-10-13       Impact factor: 3.575

9.  Acute nicotine-induced tachyphylaxis is differentially manifest in the limbic system.

Authors:  Yantao Zuo; Hanbing Lu; D Bruce Vaupel; Yi Zhang; Svetlana I Chefer; William R Rea; Anna V Moore; Yihong Yang; Elliot A Stein
Journal:  Neuropsychopharmacology       Date:  2011-07-27       Impact factor: 7.853

10.  Selective activation of the M1 muscarinic acetylcholine receptor achieved by allosteric potentiation.

Authors:  Lei Ma; Matthew A Seager; Matthew Seager; Marion Wittmann; Marlene Jacobson; Denise Bickel; Maryann Burno; Keith Jones; Valerie Kuzmick Graufelds; Guangping Xu; Michelle Pearson; Alexander McCampbell; Renee Gaspar; Paul Shughrue; Andrew Danziger; Christopher Regan; Rose Flick; Danette Pascarella; Susan Garson; Scott Doran; Constantine Kreatsoulas; Lone Veng; Craig W Lindsley; William Shipe; Scott Kuduk; Cyrille Sur; Gene Kinney; Guy R Seabrook; William J Ray
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-26       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.